The impact of COVID-19 on DR screening and treatment rates persisted even after the resumption of non-essential care services, with a discrepancy between new and established patients. Future research should work to identify and overcome the barriers to DR screening.
Keyphrases
- diabetic retinopathy
- healthcare
- end stage renal disease
- coronavirus disease
- ejection fraction
- chronic kidney disease
- sars cov
- newly diagnosed
- primary care
- optical coherence tomography
- palliative care
- prognostic factors
- peritoneal dialysis
- editorial comment
- pain management
- patient reported outcomes
- affordable care act